Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
3SBio Inc.
3SBio Inc. Approves Share Repurchase Program
April 4th, 2008
3SBio Inc. (NASDAQ:SSRX) ("3SBio" or the "Company"), a leading, fully integrated, biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, announced that its board of directors has approved a share repurchase program. The board has authorized 3SBio to purchase up to US$20 million worth of its outstanding American Depositary Shares ("ADSs"). Under the program, repurchases may be made from time to time on the open market over a period of 12 months commencing from March 21, 2008, depending on market conditions, the trading price of the ADSs and other factors, as well as subject to relevant rules...
Source: Health Business Week (2008-04-04)
|
